A retrospective examination of mean relative telomere length in the Tasmanian Familial Hematological Malignancies Study

Oncology Reports

Volumn 33, Issue 1, 2015, Pages 25-32

  Blackburn, Nicholas B ^a   Charlesworth, Jac C ^a,b   Marthick, James R ^a   Tegg, Elizabeth M ^c,d   Marsden, Katherine A ^a,c   Srikanth, Velandai ^e   Blangero, John ^b   Lowenthal, Ray M ^a,c   Foote, Simon J ^f   Dickinson, Joanne L ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^c ROYAL HOBART HOSPITAL   (Australia)

^d UNIVERSITY OF TASMANIA   (Australia)

^e MONASH UNIVERSITY   (Australia)

^f Australian National University   (Australia)

Author keywords

Familial cancer; Hematological malignancies; Telomere length

Indexed keywords

GENOMIC DNA;

ADULT; AGED; ARTICLE; AUSTRALIA; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; HEMATOLOGIC MALIGNANCY; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RELATIVE; RETROSPECTIVE STUDY; STATISTICAL MODEL; TELOMERE; TELOMERE LENGTH; ADOLESCENT; GENETICS; HEMATOLOGIC DISEASE; MIDDLE AGED; RISK FACTOR; TELOMERE SHORTENING; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TASMANIA; TELOMERE SHORTENING; YOUNG ADULT;

EID: 84916225786     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3568     Document Type: Article

References (47)

1. Moyzis RK, Buckingham JM, Cram LS, et al: A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci US A 85: 6622-6626, 1988.
2. C ounter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider C W, Harley CB and Bacchetti S: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11: 1921-1929, 1992.
3. Harley CB, Futcher AB and Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460, 1990.
4. Greider CW and Blackburn EH: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43: 405-413, 1985.
5. Allsopp RC, Vaziri H, Patterson C, et al: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci US A 89: 10114-10118, 1992.
6. Brouilette SW, Moore JS, McMahon AD, et al: Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet 369: 107-114, 2007.
7. McGrath M, Wong JYY, Michaud D, Hunter DJ and de Vivo I: Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 16: 815-819, 2007.
8. Willeit P, Willeit J, Mayr A, et al: Telomere length and risk of incident cancer and cancer mortality. JAMA 304: 69-75, 2010.
9. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L and DePinho RA: Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406: 641-645, 2000.
10. Slagboom PE, Droog S and Boomsma DI: Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet 55: 876-882, 1994.
11. Vasa-Nicotera M, Brouilette S, Mangino M, et al: Mapping of a major locus that determines telomere length in humans. Am J Hum Genet 76: 147-151, 2005.
12. Njajou OT, Cawthon RM, Damcott CM, et al: Telomere length is paternally inherited and is associated with parental lifespan. Proc Natl Acad Sci US A 104: 12135-12139, 2007.
13. Huda N, Tanaka H, Herbert BS, Reed T and Gilley D: Shared environmental factors associated with telomere length maintenance in elderly male twins. Aging Cell 6: 709-713, 2007.
14. Graakjaer J, Bischoff C, Korsholm L, et al: The pattern of chromosome-specific variations in telomere length in humans is determined by inherited, telomere-near factors and is maintained throughout life. Mech Ageing Dev 124: 629-640, 2003.
15. Graakjaer J, Londoño-Vallejo JA, Christensen K and Kølvraa S: The pattern of chromosome-specific variations in telomere length in humans shows signs of heritability and is maintained through life. Ann NY Acad Sci 1067: 311-316, 2006.
16. C hiang YJ, Calado RT, Hathcock KS, Lansdorp PM, Young NS and Hodes RJ: Telomere length is inherited with resetting of the telomere set-point. Proc Natl Acad Sci US A 107: 10148-10153, 2010.
17. Wu X, Amos CI, Zhu Y, et al: Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst 95: 1211-1218, 2003.
18. Kirwan MJ, Vulliamy T, Marrone A, et al: Defining the pathogenic role of telomerase mutations in myelodysplastic syndrome and acute myeloid leukemia. Hum Mutat 30: 1567-1573, 2009.
19. Swerdlow SH, Campo E, Harris NL, et al: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC, Lyon, 2008.
20. Goldin LR, Björkholm M, Kristinsson SY, Turesson I and Landgren O: Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia. Haematologica 94: 647-653, 2009.
21. Wu K, Lund M, Bang K and Thestrup-Pedersen K: Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma. Cancer 86: 1056-1063, 1999.
22. Terasaki Y, Okumura H, Ohtake S and Nakao S: Accelerated telomere length shortening in granulocytes: a diagnostic marker for myeloproliferative diseases. Exp Hematol 30: 1399-1404, 2002.
23. Wu KD, Orme LM, Shaughnessy J, Jacobson J, Barlogie B and Moore MAS: Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival. Blood 101: 4982-4989, 2003.
24. Hartmann U, Brümmendorf TH, Balabanov S, Thiede C, Illme T and Schaich M: Telomere length and hTER T expression in patients with acute myeloid leukemia correlates with chromosomal abnormalities. Haematologica 90: 307-316, 2005.
25. Ghaffari SH, Shayan-Asl N, Jamialahmadi AH, Alimoghaddam K and Ghavamzadeh A: Telomerase activity and telomere length in patients with acute promyelocytic leukemia: indicative of proliferative activity, disease progression, and overall survival. Ann Oncol 19: 1927-1934, 2008.
26. C apraro V, Zane L, Poncet D, et al: Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemias. Exp Hematol 39: 195-202.e2, 2011.
27. Lan Q, Cawthon R, Shen M, et al: A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma. Clin Cancer Res 15: 7429-7433, 2009.
28. Mansouri L, Grabowski P, Degerman S, et al: Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients. Am J Hematol 88: 647-651, 2013.
29. Tegg EM, Thomson RJ, Stankovich J, et al: Evidence for a common genetic aetiology in high-risk families with multiple haematological malignancy subtypes. Br J Haematol 150: 456-462, 2010.
30. Tegg EM, Thomson RJ, Stankovich JM, et al: Anticipation in familial hematologic malignancies. Blood 117: 1308-1310, 2011.
31. L owenthal RM, Tegg EM and Dickinson JL: The Familial Tasmanian Haematological Malignancies Study (FaTHMS): its origins, its history and the phenomenon of anticipation. Transfus Apher Sci 49: 113-115, 2013.
32. FitzGerald LM, Patterson B, Thomson R, et al: Identification of a prostate cancer susceptibility gene on chromosome 5p13q12 associated with risk of both familial and sporadic disease. Eur J Hum Genet 17: 368-377, 2009.
33. C allisaya ML, Blizzard L, Schmidt MD, Martin KL, McGinley JL, Sanders LM and Srikanth VK: Gait, gait variability and the risk of multiple incident falls in older people: a population-based study. Age Ageing 40: 481-487, 2011.
34. Giles GG, Lickiss JN, Baikie MJ, Lowenthal RM and Panton J: Myeloproliferative and lymphoproliferative disorders in Tasmania, 1972-80: occupational and familial aspects. J Natl Cancer Inst 72: 1233-1240, 1984.
35. L ickiss JN, Giles GG, Baikie MJ, Lowenthal RM, Challis D and Panton J: Myeloproliferative and lymphoproliferative disorders in Tasmania, 1972-80: patterns in space and time. J Natl Cancer Inst 72: 1223-1231, 1984.
36. C awthon RM: Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 37: e21, 2009.
37. Ruijter JM, Ramakers C, Hoogaars WMH, Karlen Y, Bakker O, van den Hoff MJB and Moorman AFM: Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res 37: e45, 2009.
38. Almasy L and Blangero J: Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62: 1198-1211, 1998.
39. Almasy L and Blangero J: Variance component methods for analysis of complex phenotypes. Cold Spring Harb Protoc 2010: pdb.top77-pdb.top77, 2010.
40. Njajou OT, Blackburn EH, Pawlikowska L, et al: A common variant in the telomerase RNA component is associated with short telomere length. PLoS One 5: e13048, 2010.
41. K ampstra P: Beanplot: A boxplot alternative for visual comparison of distributions. J Statistical Software 28: 1-9, 2008. http://www.jstatsoft.org/v28/c01/.
42. Aubert G, Baerlocher GM, Vulto I, Poon SS and Lansdorp PM: Collapse of telomere homeostasis in hematopoietic cells caused by heterozygous mutations in telomerase genes. PLoS Genet 8: e1002696, 2012.
43. Schröder CP, Wisman GB, de Jong S, et al: Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation. Br J Cancer 84: 1348-1353, 2001.
44. Mirabello L, Garcia-Closas M, Cawthon R, et al: Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study. Cancer Causes Control 21: 77-82, 2010.
45. Engelhardt M, Ozkaynak MF, Drullinsky P, Sandoval C, Tugal O, Jayabose S and Moore MA: Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy. Leukemia 12: 13-24, 1998.
46. Franco S, Ozkaynak MF, Sandoval C, Tugal O, Jayabose S, Engelhardt M and Moore MAS: Telomere dynamics in childhood leukemia and solid tumors: a follow-up study. Leukemia 17: 401-410, 2003.
47. Diker-Cohen T, Uziel O, Szyper-Kravitz M, Shapira H, Natur A and Lahav M: The effect of chemotherapy on telomere dynamics: clinical results and possible mechanisms. Leuk Lymphoma 54: 2023-2029, 2013.